Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
Stalicla raised $17.4m ($3.8m in a credit facility) in Series B funding led by SPRIM Global Investments

Stalicla raised $17.4m ($3.8m in a credit facility) in Series B funding led by SPRIM Global Investments

Biotech Health services Pharma

Switzerland

France

Singapore

Investments

09 January 2024

Share:

Stalicla (company)

Switzerland

Biotech Health services Pharma

Total investments received (USD): 16.06m

Round value (USD): 13.6m

Round investors: Yaday SPRIM Global Investments

Company: Stalicla

Industry: Biotech Health services Pharma

Related deals

Hemotune raises CHF 14 million with Belmondo, VP Venture Partners, Occident, Hemex and EFI Lake Geneva Ventures

Biotech Health services

Switzerland

Investments 01 March 2024

ZuriMED raised CHf 14.5m in a Series A round of funding led by Chindex Medical Limited, and joined by Yellowstone Holding AG .

Biotech Health services Manufacturing

Switzerland

China

Investments 16 July 2023

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top